Search for peptide information and you will find confident claims stacked on top of each other, often with no source underneath. Before you compare providers, it helps to separate what is verifiable from what is marketing. The most useful filter is regulatory status: what a compound legally is, and how it can legitimately reach you.
This piece walks through four named peptides and what a careful reader should confirm about each. It is general information, not medical advice. Decisions about your own care belong with a licensed clinician.
Start with legal status, not testimonials
A claim that a peptide is safe, effective, or widely used tells you little about whether you can obtain it legally. The first questions to answer are simpler. Is the compound FDA approved for any use? If not, is it available through compounding pharmacies, and under what rules? A source that skips these questions is selling a story, not information.
Compounding happens at two kinds of facilities. A 503A pharmacy compounds for an individual patient against a specific prescription. A 503B outsourcing facility makes larger batches under stricter federal oversight. Both operate only inside a licensed, prescription-based system. Anything sold as research-use-only sits outside that system and is not a legitimate way to obtain a peptide for personal use.
Semaglutide and tirzepatide
Semaglutide and tirzepatide are GLP-1 medications available as FDA-approved branded products through licensed pharmacies with a prescription. That is the clearest legal path, and it is the one most reading online should point you toward.
Compounded versions have circulated during periods when the branded drugs were listed as in shortage. Shortage status changes over time, and it directly affects what a pharmacy may legally compound. If a provider offers a compounded GLP-1, a legitimate one should be able to explain the current status plainly and name the pharmacy filling the order. Vagueness on either point is a warning sign.
Tesamorelin
Tesamorelin is an FDA-approved product for a specific indication and is dispensed through licensed pharmacies by prescription. As with any peptide, marketing that stretches it toward unrelated uses is describing something the approval does not cover. Confirm what a provider is actually prescribing it for, and whether that matches the label.
Thymosin-alpha-1
Thymosin-alpha-1 is investigational in the United States and is not FDA approved. You will see it discussed heavily in peptide circles, often with far more certainty than its regulatory position supports. Treat strong claims about it with particular care, and ask any provider offering it to be specific about its legal status and the pharmacy involved.
What actually drives cost
Price differences between providers are rarely mysterious. A branded, FDA-approved drug carries a different cost structure than a compounded preparation. Beyond the medication itself, you are often paying for the clinical visit, follow-up, lab work, and shipping. A provider that lists a single low number without explaining what it includes is not being transparent, and transparency is the thing you are shopping for.
Vetting the provider itself
Once the compound checks out, turn to the provider. A few things separate a legitimate operation from a storefront.
- A licensed clinician reviews your case and writes the prescription, rather than a checkout form standing in for a consult.
- The pharmacy filling the order is named and verifiable, and it is a licensed 503A or 503B facility.
- Claims stay inside what the compound's regulatory status supports, without efficacy promises the label does not carry.
- Pricing spells out what is included, and follow-up care is part of the arrangement.
Good information and a good provider share the same trait: they hold up when you ask specific questions. If a source or a seller gets defensive or vague about legal status, the pharmacy, or the clinician behind it, that is your answer. Bring what you find to a licensed clinician who can weigh it against your own situation.